Sandbox:UT: Difference between revisions
Usama Talib (talk | contribs) No edit summary |
Usama Talib (talk | contribs) No edit summary |
||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{familytree/start}} | |||
{{familytree | | | | | | | | | | A01 | | | | | | | | | | | A01 = Solitary thyroid nodule}} | |||
{{familytree | | | |,|-|-|-|-|-|-|+|-|-|-|-|-|-|-|-|-|-|.| | | | | | }} | |||
{{familytree | | | A01 | | | | | A02 | | | | | | | | A03 | | | | | | | A01 = Cystic nodule | A02 = Spongiform nodule | A03 = Solid nodule }} | |||
{{familytree | | | |!| | | | | | |!| | | | | |,|-|-|-|+|-|-|-|.| | | | }} | |||
{{familytree | | | |`|-| D01 |-|-|'| | | | | A01 | | A02 | | A03 | | | | A01 = Hyperechoic or isoechoic or partially cystic nodule with eccentric solid areas | A03 = Hypoechoic solid nodule or solid hypoechoic component of a partially cystic nodule WITH one or more of the following features:<br> Irregular margins <br> Microcalcifications <br> Taller than wide shape <br> Rim calcifications with small extrusive soft tissue component <br> Evidence of extrathyroidal extension | |||
| A02 = Hypoechoic solid nodule with smooth margins WITHOUT the following features: <br> Microcalcifications<br> Extrathyroidal extension <br> Taller than wider shape | D01 = Without malignant features }} | |||
{{familytree | | | | | | |!| | | | | | | | | |!| | | |!| | | |!| | | | | }} | |||
{{familytree | | | | | | S01 | | | | | | | | A01 | | A02 | | A03 | | | | A01 = '''Low suspicion for malignancy''' | A02 = '''Intermediate suspicion of malignancy''' | A03 = '''High suspicion of malignancy''' | S01 = '''Very low suspicion of malignncy''' }} | |||
{{familytree | | | | | | |:| | | | | | | | | |:| | | |:| | | |:| | | | | }} | |||
{{familytree | | | | | | |:| | | | | | | | | |:| | | |:| | | |:| }} | |||
{{familytree | | | | | | |:| | | | | | | | | A01 | | |:| | | |:| | | A01 = Estemated risk of malignancy }} | |||
{{familytree | | | | | | |:| | | | | | | | | |:| | | |:| | | |:| }} | |||
{{familytree | | | | | | |:| | | | | | | | | |:| | | |:| | | |:| | | | | }} | |||
{{familytree | | | | | | S01 | | | | | | | | A01 | | A02 | | A03 | | | | S01 = <3% | A01 = 5 to 10% | A02 = 10 to 20% | A03 = >70 to 90% }} | |||
{{familytree | | | | | | |!| | | | | | | | | |!| | | |`|-|v|-|'| | | | | }} | |||
{{familytree | | | | | | S01 | | | | | | | | A01 | | | | B01 | | | | | | S01 = FNA if nodule is larger that 2cm | A01 = FNA if nodule is larger that 1.5cm | B01 = FNA if nodule is larger that 1cm}} | |||
{{familytree/end}} | |||
{| class="wikitable" | {| class="wikitable" |
Revision as of 17:34, 11 September 2017
Solitary thyroid nodule | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Cystic nodule | Spongiform nodule | Solid nodule | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Without malignant features | Hyperechoic or isoechoic or partially cystic nodule with eccentric solid areas | Hypoechoic solid nodule with smooth margins WITHOUT the following features: Microcalcifications Extrathyroidal extension Taller than wider shape | Hypoechoic solid nodule or solid hypoechoic component of a partially cystic nodule WITH one or more of the following features: Irregular margins Microcalcifications Taller than wide shape Rim calcifications with small extrusive soft tissue component Evidence of extrathyroidal extension | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Very low suspicion of malignncy | Low suspicion for malignancy | Intermediate suspicion of malignancy | High suspicion of malignancy | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Estemated risk of malignancy | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
<3% | 5 to 10% | 10 to 20% | >70 to 90% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
FNA if nodule is larger that 2cm | FNA if nodule is larger that 1.5cm | FNA if nodule is larger that 1cm | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Wikidoc Internal Medicine Texbook | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Subject | Endocrinology | Gastroenterology | Rheumatology | Pulmonology | Nephrology | Hematology | Total | ||||||
Number of Microchapters | Total | Left | Total | Left | Total | Left | Total | Left | Total | Left | Total | Left | |
71 | 39 | 96 | 89 | 54 | 47 | 58 | 46 | 59 | 64 | 51 | 47 | 332 | |
Projected Microchapters | 50 | 111 | 59 | 59 | 80 | 59 | 418 | ||||||
Days Projected
|
35 days | 75 days | 40 days | 40 days | 55 days | 40 days | 280 days | ||||||
Review Processing Time (days) | 14 | 14 | 14 | 14 | 14 | 14 | 84 days | ||||||
Expected Time for each Chapter (days) | 49 | 89 | 54 | 54 | 69 | 54 | 364 days | ||||||
Expected Time line | October 2017, 1st week | January 2018,1st week | February 2018, 4th week | April 2018, 3rd week | July 2018, 1st week | August 2018, 4th week |
Wikidoc Other Textbooks | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Subject | Psychiatry | Neurology | Peds/Developmental | Dermatology | ObGyn | Ophthalmology | Nutrition | Total | |||||||
Number of Microchapters | Total | Left | Total | Left | Total | Left | Total | Left | Total | Left | Total | Left | Total | Left | |
36 | 36 | 77 | 71 | 49 | 49 | 18 | 14 | 33 | 27 | 18 | 17 | 17 | 15 | 229 | |
Projected Microchapters | 45 | 89 | 60 | 17 | 35 | 21 | 19 | 286 | |||||||
Days projected
|
30 days | 60 days | 40 days | 14 days | 21 days | 16 days | 15 days | 196 days | |||||||
Review Processing Time (days) | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 98 days | |||||||
Expected Time for each Chapter (days) | 44 | 74 | 54 | 28 | 35 | 30 | 29 | 294 days | |||||||
Expected Time Line | October 2018, 3rd week | January 2019, 1st week | March 2019, 1st week | April 2019, 1st week | May 2019, 2nd week | June 2019, 2nd week | July 2019, 2nd week |
Viral Hepatitis | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Hepatitis A | Hepatitis B | Hepatitis C | Hepatitis D | Hepatitis E | Hepatitis F | Hepatitis G | Other | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
• EBV hepatitis • CMV hepatitis • HSV hepatitis • Coxsackie B virus hepatitis | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Non-infectious Hepatitis | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Alcoholic hepatitis | Non-alcoholic steatohepatitis (NASH) | a-1 antitrypsin defieciency | Autoimmune hepatitis | Obstructive hepatitis | Drug related hepatitis | Toxin related hepatitis | Ischemic hepatitis | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
•Gall stone •Tumor | •Isoniazid •NSAIDs •Beta-lactam antibiotics •Sulfa-containing drugs •HAART | Chemicals | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Obsessive compulsive disorder RSG
Obsessive compulsive disorder | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Screen for OCD; if present, assess severity and associated conditions* | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Mild to moderate OCD, Patient has good insight | Severe OCD OR Pateint has poor insight OR Moderate to severe co-occuring hoarding, tics, depresion or anxiety disorder | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Improvement within 12 weeks? | Improvement within 12 weeks | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Negative Culture ❑ Complete 5 day Antibiotic Course | Confirmed SBP ❑ Narrow the spectrum based on the susceptibility to complete the 5 day course | Culture Negative ❑ No Antibiotics indicated | Culture Positive ❑ Bacterascites: Repeat diagnostic paracentesis when the culture growth is discovered | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Code to Fix Refereneces
Classification
UTI | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Uppper | Lower | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Pyelonephritis | Cystitis | Prostatitis | Uretheritis | Asymptomatic Bacteriuria | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Pyelonephritis | Etiology | Pathogen | Duration and Treatment | Acute Bacterial*Chronic bacterial*Inflammatory chronic*Non-inflammatory chronic*Asymptomatic | Non-infectious | Infectious | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
*Traumatic cystitis*Interstitial Cystitis*Eosinophilic cystitis*Hemorrhagic cystitis*Foreign body cystitis*Cystitis cystica*Emphysematous cystitis*Cystitis glandularis | *Bacteria*Fungi*Viruses*Parasites | *Acute uncomplicated cystitis*Complicated cystitis*Recurrent/Chronic Cystitis | *urinary crystals*Chemicals*Stevens-Johnson syndrome*Spermicides | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Journal Reference
Raas-Rothschild A, Spiegel R (2010 Jan 28). "Mucolipidosis III Gamma". GeneReviews®. PMID 20301784. Check date values in: |access-date=, |date=
(help); |access-date=
requires |url=
(help)
Book Reference
Pathology image reference/website
Radiopedia Image reference
Color codes for table
BLUE: |align="center" style="background:#4479BA; color: #FFFFFF;" |
GRAY: |style="background: #F5F5F5; padding: 5px text-align:center" | +
KHAKI:|style="background: #F0E68C; padding: 5px text-align:center" | +
PALE TORQOUI...:|style="background: #AFEEEE; padding: 5px text-align:center" | -
Brown:|style="background: #A52A2A; padding: 5px text-align:center" | +
Image copying
Image copying with text
Table for D/D of cystitis
Diseases | Diagnostic tests | Physical Examination | Symptoms | Past medical history | Other Findings | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Urinalysis | Urine Culture | Gold Standard | Fever | Suprapubic Tenderness | Discharge | Inguinal Lymphadenopathy | Hematuria | Pyuria | Frequency | Urgency | Dysuria | |||
Cystitis | *Nitrite +ve
*Leukocyte estrase+ve *WBCs *RBCs |
>100,000CFU/mL | Urinary culture | ✔ | ✔ | - | ✔ | ✔ | ✔ | ✔ | ✔ | ✔ |
| |
Urethritis | *Positive leukocyte esterase test or >10 WBCs
*Mucous threads in the morning urine |
- | *Gram stain
*Mucoid or purulent discharge |
✔ | - | Urethral discharge | ✔ | - | ✔ | - | - | ✔ |
|
Tachycardia, diaphoresis, hypertension, tremors, mydriasis, positional nystagmus, tachypnea |
Bacterial Vulvovagintis | - | - | Gram Stain | ✔ | - | Vaginal discharge | ✔ |
|
| |||||
Cervicitis | - | - | culture for gonococcal cervicitis | ✔ | - |
endocervical exudate |
- | ✔ | - | - | ✔ |
|
1-a purulent or mucopurulent endocervical exudate
2-Sustained endocervical bleeding easily induced by a cotton swab 3->10 WBC in vaginal fluid, in the absence of trichomoniasis, may indicate endocervical inflammation caused specifically by C. trachomatis or N. gonorrhea | |
Prostatitis | 10-20 leukocytes for acute and chronic bacterial subtypes | Identifies causative bacteria (in bacterial subtypes) |
|
✔ | - | - | - | ✔ | ✔ | ✔ | ✔ |
|
||
Epididymitis | Hematuria may be seen | ✔ | Culture | ✔ | ✔ | +/- urethral discharge | ✔ | ✔ | - | ✔ | ✔ | ✔ |
|
*Ultrasound in patients with acute testicular pain to assess for testicular torsion
|
Syphilis (STD) | - | - | Darkfield Microscopy | +/- | - | - | ✔ | - | - | - | - | - |
|
|
BPH | Recommended
Hematuria may be seen |
- | DRE + Serum PSA | - | - | - | ✔ | - | ✔ | ✔ | ✔ |
|
| |
Neoplasms | Recomended
Hematuria may be seen |
- | Imaging and biopsy | +- | - | ✔ | ✔ | - | ✔ | ✔ | - |
|
| |
Pyelonephritis |
|
Identifies causative bacteria | Imaging and culture | ✔ | ✔ + Flank Pain | ✔ | ✔ | ✔ | ✔ | ✔ |
|
|
References
- ↑ Braunwald, Eugene. Heart Disease- Fourth Edition. Harvard Medical School: W. B. SAUNDERS COMPANY. p. 1137. ISBN 0-7216-3097-9.
- ↑ Libre Pathology https://librepathology.org/wiki/File:Cystitis_cystica_et_glandularis_-_alt_--_intermed_mag.jpg Accessed on Jan 13, 2017
- ↑ Radiopaedia.org. Case courtesy of Dr David Little. From the case <a href="https://radiopaedia.org/cases/39307">rID: 39307